368441-44-5

Basic information

• Product Name: 2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate
• Synonyms: 2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate;1,3-Dihydro-2H-isoindole-2,5-dicarboxylic acid 2-(tert-butyl) 5-methyl ester;N-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)isoindoline;2-(tert-butoxycarbonyl)-1-methylisoindoline-5-carboxylate;2H-Isoindole-2,5-dicarboxylic acid, 1,3-dihydro-, 2-(1,1-dimethylethyl) 5-methyl ester;TERT-BUTYL METHYL ISOINDOLINE-2,5-DICARBOXYLATE
• CAS NO: 368441-44-5
• Molecular Formula: C15H19NO4
• Molecular Weight: 277
• Mol File: 368441-44-5.mol

Chemical Properties

• Appearance: /
• Density: 1.181
• CAS DataBase Reference: 2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate(368441-44-5)
• EPA Substance Registry System: 2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate(368441-44-5)

Safety Data

• Hazardous Substances Data: 368441-44-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate is used as an intermediate in the synthesis of pharmaceuticals for its potential as a bioactive molecule. Its anti-inflammatory and antioxidant properties contribute to the development of new drugs with therapeutic benefits.
Used in Agrochemical Industry:
In the agrochemical industry, 2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate is used as an intermediate in the synthesis of agrochemicals, leveraging its bioactive properties to create compounds with potential applications in agriculture.
Used in Organic Synthesis:
2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate is used as a building block in the synthesis of various organic compounds. Its versatility in organic reactions allows for the preparation of new chemical entities with potential applications in various fields.
Used in Research and Development:
2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate is utilized in research and development for the exploration of its anti-inflammatory and antioxidant properties, as well as its potential applications in drug development and other industries.

Upstream product

• 201940-08-1 5-bromo-1,3-dihydro-isoindole-2-carboxylic acid tert-butyl ester 
• 127168-94-9 methyl 2,3-dihydro-2-(phenylmethyl)-1H-isoindole-5-carboxylate 
• 691-64-5 di-tert-butyl oxalate 
• 201230-82-2 carbon monoxide 
• 67-56-1 methanol 
• 3375-31-3 palladium diacetate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 127168-84-7 5-bromoisoindoline 
• 86-90-8 4-bromophthalic anhydride 
• 6941-75-9 5-Bromoisoindoline-1,3-dione 

Downstream Products

• 149353-71-9 2-(tert-butoxycarbonyl)isoindoline-5-carboxylic acid 
• 742666-57-5 methyl isoindoline-5-carboxylate 
• 253801-14-8 tert-butyl 5-(hydroxymethyl)-1,3-dihydro-2H-isoindole-2-carboxylate 
• 685565-60-0 N-[4-(3-piperidin-1-ylpropoxy)benzoyl]-5-cyanoisoindoline 
• 263888-56-8 tert-butyl 5-cyanoisoindoline-2-carboxylate 
• 253801-15-9 5-formyl-1,2-dihydro-isoindole-2-carboxylic acid tertiary butyl ester 

Relevant articles and documents

ISOINDOLINE DERIVATIVES WHICH BIND TO AN ATP BINDING SITE

The present invention relates to novel probe compounds of formulae I and II defined herein. The present invention also relates to methods of synthesising these novel probe compounds and to their use in assays and screens for determining the binding of a test molecule to the ATP-binding site of a target protein, such as, for example, the Mismatch Repair (MMR) component proteins PMS2 and MLH1, or for determining the location and/or quantity of such target proteins in a biological sample.

2-Amino-2,3-dihydro-1 H-indene-5-carboxamide-Based Discoidin Domain Receptor 1 (DDR1) Inhibitors: Design, Synthesis, and in Vivo Antipancreatic Cancer Efficacy

A series of 2-amino-2,3-dihydro-1H-indene-5-carboxamides were designed and synthesized as new selective discoidin domain receptor 1 (DDR1) inhibitors. One of the representative compounds, 7f, bound with DDR1 with a Kd value of 5.9 nM and suppre

HETEROCYCLIC COMPOUND

The problem of the present invention is to provide a compound having a superior RORγt inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like. The present invention relates to a compound represented by the formula (I): [wherein each symbol is as described in the DESCRIPTION] or a salt thereof, which has an RORγt inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like.

Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof

Benzenesulfonyl-asymmetric ureas are provided for the treatment of conditions modulated by the ghrelin receptor.

HETERO-HALO INHIBITORS OF HISTONE DEACETYLASE

This invention provides compounds that are inhibitors of HDAC2. The compounds (e.g., compounds according to Formula I, II or any of Compounds 100-128 or any of those in Tables 2 or 3) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological disease, or neoplastic disease, or for improving memory or treating, alleviating, or preventing memory loss or impairment.

MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULFONAMIDES AS INHIBITORS OF HCV REPLICATION

The present invention provides compounds of the general formulas I-IX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The present invention further provides treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

Macrocyclic compounds as inhibitors of viral replication

The embodiments provide compounds of the general formulas I-XIX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating flaviviral infection, including hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

BICYCLIC BENZAMIDE COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGAND USEFUL IN THE TREATMENT OF NEUROLOGICAL DISEASES

The present invention relates to novel bicyclic benzamide derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.